S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Major Financial Crisis Could Hit America (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Major Financial Crisis Could Hit America (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Major Financial Crisis Could Hit America (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Asian shares mostly rise after House approves debt ceiling deal
Major Financial Crisis Could Hit America (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
NASDAQ:ISPC

iSpecimen (ISPC) Stock Forecast, Price & News

$1.33
+0.12 (+9.92%)
(As of 05/31/2023 ET)
Compare
Today's Range
$1.23
▼
$1.33
50-Day Range
$1.22
▼
$1.88
52-Week Range
$1.17
▼
$3.26
Volume
24,112 shs
Average Volume
26,162 shs
Market Capitalization
$12.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.63
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

iSpecimen MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
473.3% Upside
$7.63 Price Target
Short Interest
Healthy
0.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.44 out of 5 stars

Medical Sector

216th out of 1,006 stocks

Commercial Physical Research Industry

7th out of 16 stocks

See Top Rated MarketRank™ Stocks Here

ISPC stock logo

About iSpecimen (NASDAQ:ISPC) Stock

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

May 23, 2023 | finance.yahoo.com
iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023
May 18, 2023 | msn.com
Looking Into iSpecimen's Return On Capital Employed
June 1, 2023 | Legacy Research (Affiliate) (Ad)
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin
$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.
May 4, 2023 | finance.yahoo.com
iSpecimen Reports First Quarter 2023 Results
April 24, 2023 | finance.yahoo.com
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023
April 20, 2023 | finance.yahoo.com
iSpecimen to Report First Quarter 2023 Results on May 4, 2023
April 19, 2023 | americanbankingnews.com
Contrasting iSpecimen (ISPC) and Its Rivals
April 18, 2023 | finance.yahoo.com
Market Might Still Lack Some Conviction On iSpecimen Inc. (NASDAQ:ISPC) Even After 33% Share Price Boost
June 1, 2023 | Legacy Research (Affiliate) (Ad)
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin
$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.
April 18, 2023 | americanbankingnews.com
iSpecimen (ISPC) and Its Rivals Head-To-Head Analysis
April 18, 2023 | americanbankingnews.com
Contrasting iSpecimen (ISPC) & Its Peers
April 17, 2023 | americanbankingnews.com
Reviewing iSpecimen (ISPC) and The Competition
April 16, 2023 | americanbankingnews.com
Financial Analysis: iSpecimen (ISPC) versus Its Peers
April 16, 2023 | americanbankingnews.com
Contrasting iSpecimen (NASDAQ:ISPC) & bioAffinity Technologies (NASDAQ:BIAF)
April 15, 2023 | americanbankingnews.com
iSpecimen (ISPC) vs. Its Competitors Head-To-Head Comparison
April 15, 2023 | americanbankingnews.com
iSpecimen (ISPC) and Its Competitors Financial Survey
April 14, 2023 | americanbankingnews.com
iSpecimen (ISPC) vs. Its Competitors Financial Contrast
April 12, 2023 | americanbankingnews.com
Critical Review: iSpecimen (ISPC) and Its Peers
April 12, 2023 | americanbankingnews.com
Head-To-Head Review: iSpecimen (ISPC) and Its Competitors
April 11, 2023 | americanbankingnews.com
iSpecimen (ISPC) versus Its Rivals Head to Head Survey
April 11, 2023 | americanbankingnews.com
Financial Survey: iSpecimen (ISPC) and Its Peers
April 11, 2023 | americanbankingnews.com
Head-To-Head Survey: iSpecimen (ISPC) & The Competition
April 10, 2023 | americanbankingnews.com
iSpecimen (ISPC) & Its Competitors Critical Comparison
April 10, 2023 | americanbankingnews.com
Contrasting iSpecimen (ISPC) & The Competition
April 8, 2023 | americanbankingnews.com
iSpecimen (ISPC) & Its Rivals Head to Head Contrast
April 8, 2023 | americanbankingnews.com
Financial Review: iSpecimen (ISPC) vs. Its Peers
April 7, 2023 | americanbankingnews.com
Analyzing iSpecimen (ISPC) and Its Peers
See More Headlines
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Company Calendar

Last Earnings
3/14/2023
Today
6/01/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ISPC
CUSIP
N/A
CIK
1558569
Web
ispecimen.com
Phone
781-301-6700
Fax
N/A
Employees
59
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.63
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$4.25
Forecasted Upside/Downside
+473.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,250,000.00
Net Margins
-95.03%
Pretax Margin
-95.02%
Return on Equity
-47.82%
Return on Assets
-39.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.14
Quick Ratio
4.14

Sales & Book Value

Annual Sales
$10.83 million
Price / Sales
1.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.00 per share
Price / Book
0.67

Miscellaneous

Outstanding Shares
9,029,000
Free Float
6,077,000
Market Cap
$12.01 million
Optionable
Not Optionable
Beta
1.94

Key Executives

  • Ms. Tracy Wilson Curley (Age 60)
    CFO, Treasurer & Interim CEO
    Comp: $367k
  • Dr. Christopher J. Ianelli M.D. (Age 54)
    Ph.D., Founder & Director
    Comp: $440k
  • Mr. Benjamin Bielak (Age 52)
    Chief Information Officer
    Comp: $334k
  • Ms. Jill Mullan (Age 57)
    Sec. & Director
    Comp: $391.25k
  • Ms. Dawn Michelle
    VP of Operations
  • Mr. Eric Langlois
    Sr. VP of Sales & Bus. Devel.
  • Ms. Carly Lejnieks
    VP of Marketing
  • Ms. Emily Hubbard
    VP of Site Management & Devel.
  • Mr. David Wages M.D.
    Ph.D., Chief Medical Officer

Key Competitors

View All Competitors













ISPC Stock - Frequently Asked Questions

Should I buy or sell iSpecimen stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iSpecimen in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ISPC shares.
View ISPC analyst ratings or view top-rated stocks.

What is iSpecimen's stock price forecast for 2023?

1 analysts have issued 1-year price targets for iSpecimen's stock. Their ISPC share price forecasts range from $4.25 to $11.00. On average, they predict the company's stock price to reach $7.63 in the next twelve months. This suggests a possible upside of 473.3% from the stock's current price.
View analysts price targets for ISPC or view top-rated stocks among Wall Street analysts.

How have ISPC shares performed in 2023?

iSpecimen's stock was trading at $1.3750 at the beginning of the year. Since then, ISPC stock has decreased by 3.3% and is now trading at $1.33.
View the best growth stocks for 2023 here.

Are investors shorting iSpecimen?

iSpecimen saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 28,100 shares, a drop of 43.0% from the April 30th total of 49,300 shares. Based on an average trading volume of 30,900 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.5% of the shares of the company are short sold.
View iSpecimen's Short Interest.

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our ISPC earnings forecast.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) announced its earnings results on Tuesday, March, 14th. The company reported ($0.24) earnings per share (EPS) for the quarter. The business had revenue of $2.96 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 47.82% and a negative net margin of 95.03%.

When did iSpecimen IPO?

(ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

What is iSpecimen's stock symbol?

iSpecimen trades on the NASDAQ under the ticker symbol "ISPC."

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iSpecimen's stock price today?

One share of ISPC stock can currently be purchased for approximately $1.33.

How much money does iSpecimen make?

iSpecimen (NASDAQ:ISPC) has a market capitalization of $12.01 million and generates $10.83 million in revenue each year. The company earns $-10,250,000.00 in net income (profit) each year or ($1.16) on an earnings per share basis.

How can I contact iSpecimen?

The official website for the company is ispecimen.com. The company can be reached via phone at 781-301-6700 or via email at ispecimen@kcsa.com.

This page (NASDAQ:ISPC) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -